These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Proceedings: A therapeutic trial of epsikapron. So SC; Sengupta RP J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):827. PubMed ID: 1185214 [No Abstract] [Full Text] [Related]
10. Experimental epsilon-aminocaproic acid (EACA) administration in the presence of subarachnoid blood. Ewald T; Mahaley S; Goodrich J; Wilkinson R; Silver D J Neurosurg; 1971 Dec; 35(6):657-63. PubMed ID: 5171110 [No Abstract] [Full Text] [Related]
11. Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage. Chowdhary UM; Sayed K J Neurol Neurosurg Psychiatry; 1981 Sep; 44(9):810-3. PubMed ID: 7031186 [TBL] [Abstract][Full Text] [Related]
12. Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid. Sonntag VK; Stein BM J Neurosurg; 1974 Apr; 40(4):480-5. PubMed ID: 4814379 [No Abstract] [Full Text] [Related]
13. Medical management of patients following a ruptured cerebral aneurysm, with epsilon-aminocaproic acid, kanamycin, and reserpine. Knuckey NW; Stokes BA Surg Neurol; 1982 Mar; 17(3):181-5. PubMed ID: 7079936 [TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment. Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294 [TBL] [Abstract][Full Text] [Related]
15. Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm. Ameen AA; Illingworth R J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):220-6. PubMed ID: 7229645 [TBL] [Abstract][Full Text] [Related]
16. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms. Burchiel KJ; Schmer G J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112 [TBL] [Abstract][Full Text] [Related]
17. [Letter: Thrombotic complications in cases of subarachnoid hemorrhages treated with epsilon-aminocaproic acid]. Neurol Neurochir Pol; 1976; 10(3):435-6. PubMed ID: 951033 [No Abstract] [Full Text] [Related]
18. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm. Ramirez-Lassepas M Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208 [TBL] [Abstract][Full Text] [Related]
19. Biochemical changes after spontaneous subarachnoid haemorrhage. 3. Coagulation and lysis with special reference to recurrent haemorrhage. Uttley AH; Buckell M J Neurol Neurosurg Psychiatry; 1968 Dec; 31(6):621-7. PubMed ID: 5709849 [No Abstract] [Full Text] [Related]
20. Antifibrinolytics in the treatment of subarachnoid hemorrhage due to rupture of arterial aneurysm. Schisano G J Neurosurg Sci; 1974; 18(1):39-46. PubMed ID: 4549070 [No Abstract] [Full Text] [Related] [Next] [New Search]